Screener

Eligibility screening

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Sponsored by National Cancer Institute (NCI)Study detailsClinicalTrials.gov

4 US sites in FL, MD, OK

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.